NARCOMEDI
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Turnover ≈ €270,000. Estimated: probably between €230,000 and €350,000.
Balance sheet
balance sheet total €318,602 on 31-12-2025in euro
in euro
Position in the sector
68.1%
Higher than 55% of 21,368 companies in 2025.
4.12
Higher than 63% of 20,917 companies in 2025.
29.6%
Higher than 65% of 21,218 companies in 2025.
Net result: middle half · Equity: middle half · Balance sheet total: middle half · Working capital: middle half
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Balance sheet: assets | ||||
20/58 |
318,602 | 219,224 | 147,217 | |
21/28 |
29,734 | 47,154 | 64,574 | |
21 |
1,096 | 2,279 | 3,462 | |
22/27 |
27,898 | 44,135 | 60,372 | |
23 |
314 | 1,319 | 2,324 | |
24 |
27,584 | 42,816 | 58,048 | |
28 |
740 | 740 | 740 | |
29/58 |
288,868 | 172,069 | 82,643 | |
40/41 |
156,764 | 92,787 | 63,793 | |
41 |
156,764 | 92,787 | 63,793 | |
54/58 |
132,104 | 79,282 | 18,850 | |
| Balance sheet: equity and liabilities | ||||
10/49 |
318,602 | 219,224 | 147,217 | |
10/15 |
216,959 | 122,531 | 65,518 | |
10/11 |
3,000 | 3,000 | 3,000 | |
14 |
213,959 | 119,531 | 62,518 | |
17/49 |
101,644 | 96,693 | 81,699 | |
17 |
31,512 | 46,231 | 60,902 | |
170/4 |
31,512 | 46,231 | 60,902 | |
42/48 |
70,132 | 50,462 | 20,797 | |
44 |
23,250 | 8,859 | 254 | |
440/4 |
23,250 | 8,859 | 254 | |
45 |
46,675 | 41,603 | 20,543 | |
450/3 |
46,675 | 41,603 | 20,543 | |
47/48 |
207 | - | - | |
| Income statement | ||||
9900 |
142,694 | 101,432 | 102,837 | |
62 |
6,292 | 2,250 | - | |
630 |
17,420 | 17,420 | 18,889 | |
640/8 |
1,906 | 2,463 | 1,717 | |
9901 |
117,075 | 79,299 | 82,231 | |
65/66B |
2,191 | 2,227 | 3,170 | |
65 |
2,191 | 2,227 | 3,170 | |
9903 |
114,885 | 77,072 | 79,061 | |
67/77 |
20,457 | 20,060 | 16,543 | |
9904 |
94,428 | 57,012 | 62,518 | |
9905 |
94,428 | 57,012 | 62,518 | |
| Appropriation of the result | ||||
9906 |
213,959 | 119,531 | 62,518 | |
14P |
119,531 | 62,518 | - | |
| Document | ||||
The notes to these accounts have 9 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 27-07-2026.
Filings
each dot is a set of accounts, on the day it reached the National BankKey figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| 134,495 | 96,719 | 101,120 | ||
| 111,848 | 74,432 | 81,408 | ||
| 0 | 0 | 83,464 | ||
| 52,822 | 60,432 | - | ||
| 218,736 | 121,607 | 61,846 | ||
| 68.1% | 55.9% | 44.5% | ||
| 4.12 | 3.41 | 3.97 | ||
| 0.47 | 0.79 | 1.25 | ||
| 43.5% | 46.5% | 95.4% | ||
| 29.6% | 26.0% | 42.5% | ||
| 61.40 | 43.44 | 31.90 |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Investments
fixed assets acquired| Item | 2025 | 2024 | 2023 |
|---|---|---|---|
| Tangible fixed assets | - | - | €79,174 |
| Intangible fixed assets | - | - | €3,550 |
| Financial fixed assets | - | - | €740 |
| €17,420 | €17,420 | €18,889 |
Source: notes to the 2023 to 2025 annual accounts (statement of fixed assets)
Insights on NARCOMEDI
The operating result for 2025 is 48% higher than in 2024 and the highest since 2023. It is a recovery after the fall in 2024.
Debt's share of the balance-sheet total falls from 44.1% to 31.9%. Equity and debt are higher.